Detalles de la búsqueda
1.
Induction of cytotoxic effector cells towards cholangiocellular, pancreatic, and colorectal tumor cells by activation of the immune checkpoint CD40/CD40L on dendritic cells.
Cancer Immunol Immunother
; 70(5): 1451-1464, 2021 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-33180184
2.
Cross-sectional increase of adherence to multidisciplinary tumor board decisions.
BMC Cancer
; 18(1): 936, 2018 Sep 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-30268109
3.
A Step-by-Step Clinical Approach for the Management of Neuroendocrine Tumours.
Horm Metab Res
; 49(2): 77-85, 2017 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-28099977
4.
Association of transcobalamin c. 776C>G with overall survival in patients with primary central nervous system lymphoma.
Br J Cancer
; 107(11): 1840-3, 2012 Nov 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-23099805
5.
Use of a SCID mouse/human lymphoma model to evaluate cytokine-induced killer cells with potent antitumor cell activity.
J Exp Med
; 174(1): 139-49, 1991 Jul 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-1711560
6.
Sequential Hodgkin's and non-Hodgkin's lymphoma in non-immunocompromised patients.
Ann Hematol
; 92(11): 1565-7, 2013 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-23558907
7.
Thalidomide in newly diagnosed multiple myeloma: influence of thalidomide treatment on peripheral blood stem cell collection yield.
Leukemia
; 21(6): 1294-9, 2007 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-17377586
8.
DNMT3A mutant transcript levels persist in remission and do not predict outcome in patients with acute myeloid leukemia.
Leukemia
; 32(1): 30-37, 2018 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28643785
9.
[Lutetium-177-PSMA radioligand therapy : Consensus within the framework of GKV-funded care between the university hospitals in Aachen, Bonn, Düsseldorf, Essen, and Cologne and the MDK Nordrhein]. / Lutetium-177-PSMA-Radioligandentherapie : Konsensus im Rahmen der GKV-finanzierten Versorgung zwischen den Hochschulkliniken in Aachen, Bonn, Düsseldorf, Essen und Köln und dem MDK Nordrhein.
Urologe A
; 57(6): 709-713, 2018 Jun.
Artículo
en Alemán
| MEDLINE | ID: mdl-29671080
10.
Final results of a randomized trial comparing 1, 3, or 6 infusions of Rituximab plus 6 cycles CHOP provide valuable preliminary data towards a more cost-effective and safer treatment of advanced follicular lymphoma.
Am J Hematol
; 87(10): E68-71, 2012 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-22847344
11.
High-dose chemotherapy with autologous haematopoietic stem cell support for relapsed or refractory primary CNS lymphoma: a prospective multicentre trial by the German Cooperative PCNSL study group.
Leukemia
; 31(12): 2623-2629, 2017 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-28559537
12.
Chromosomal aberrations in 130 patients with multiple myeloma studied by interphase FISH: diagnostic and prognostic relevance.
Cancer Genet Cytogenet
; 167(1): 20-5, 2006 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-16682281
13.
Long-term outcome of patients with newly diagnosed chronic myeloid leukemia: a randomized comparison of stem cell transplantation with drug treatment.
Leukemia
; 30(3): 562-9, 2016 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-26464170
14.
Coculture with dendritic cells promotes proliferation but not cytotoxic activity of gamma/delta T cells.
Immunol Lett
; 99(1): 103-8, 2005 Jun 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-15894118
15.
An evidence-based evaluation of important aspects of empirical antibiotic therapy in febrile neutropenic patients.
Clin Microbiol Infect
; 11 Suppl 5: 17-23, 2005 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-16138815
16.
Antifungal prophylaxis with itraconazole in neutropenic patients with acute leukaemia.
Leukemia
; 12(9): 1338-43, 1998 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-9737680
17.
Current clinical and laboratory strategies to augment the efficacy of immunotherapy in multiple myeloma.
Clin Cancer Res
; 7(8): 2195-204, 2001 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-11489792
18.
Phenotypic characterization and identification of effector cells involved in tumor cell recognition of cytokine-induced killer cells.
Exp Hematol
; 21(13): 1673-9, 1993 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-7694868
19.
Phase III trial of bortezomib, cyclophosphamide and dexamethasone (VCD) versus bortezomib, doxorubicin and dexamethasone (PAd) in newly diagnosed myeloma.
Leukemia
; 29(8): 1721-9, 2015 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-25787915
20.
Therapeutic vaccination against metastatic carcinoma by expression-modulated and immunomodified autologous tumor cells: a first clinical phase I/II trial.
Hum Gene Ther
; 12(3): 267-78, 2001 Feb 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-11177563